Roivant Sciences Ltd (ROIV)

Operating profit margin

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Operating income (ttm)	US$ in thousands	4,242,013	4,273,847	-1,165,110	-1,169,422	-1,175,318	-1,207,955	-1,075,901	-1,479,564	-1,351,642
Revenue (ttm)	US$ in thousands	90,017	87,063	67,973	44,317	33,312	22,259	36,493	44,730	48,245
Operating profit margin		4,712.46%	4,908.91%	-1,714.08%	-2,638.77%	-3,528.21%	-5,426.82%	-2,948.24%	-3,307.77%	-2,801.62%

March 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $4,242,013K ÷ $90,017K
= 4,712.46%

Roivant Sciences Ltd's operating profit margin has shown significant fluctuations over the past few quarters. In the most recent quarter ending March 31, 2024, the operating profit margin was exceptionally high at 4,712.46%, indicating that the company generated a substantial profit from its core operations relative to its revenue.

However, this high operating profit margin follows a slightly lower figure in the previous quarter, ending December 31, 2023, at 4,908.91%. In September 2023, the operating profit margin was negative at -1,714.08%, suggesting that the company experienced losses from its operations during that period.

The negative trend in operating profit margins continued in the quarters ending June 30, 2023, March 31, 2023, and December 31, 2022, with values of -2,638.77%, -3,528.21%, and -5,426.82%, respectively. These figures indicate that the company's operating expenses exceeded its operating income during those periods.

Despite the fluctuations, the operating profit margin improved from the negative values in the earlier quarters to positive figures in the most recent quarters. It is important for Roivant Sciences Ltd to closely monitor and manage its operating expenses to ensure sustained profitability and operational efficiency in the future.